Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Business</strong> <strong>Potential</strong> <strong>for</strong> <strong>Agricultural</strong> <strong>Biotechnology</strong> Products<br />
erratic. Of an average volume of 109,525 mt per year, 92% goes to domestic consumption as<br />
food, 6% is processed/wasted, and only 2% is exported (Payot, 2005).<br />
Table 6. Papaya Cultivars/Strains, Philippines<br />
Cultivars/ Weight Grown in Principal Market PRSV<br />
strains<br />
use<br />
resistance<br />
Solo About 0.45 kg Large farms Dessert Export and Susceptible<br />
in Mindanao fruit domestic<br />
Cavite Special More than 3 kg In Cavite and Dessert Domestic Susceptible<br />
neighboring<br />
provinces<br />
fruit<br />
Legaspi Special More than 3 kg In Legaspi Dessert Domestic Susceptible<br />
(Albay) and<br />
neighboring<br />
provinces<br />
fruit<br />
Morado – In Mindanao Canning Export Susceptible<br />
DMPI (devel- – In Mindanao Canned Export Susceptible<br />
oped by Del<br />
tropical<br />
Monte Philip-<br />
fruit<br />
pines, Inc.)<br />
cocktail<br />
Hybrid Sinta 1.2–2 kg In Luzon Dessert Domestic Moderately<br />
(released by<br />
UPLB–IPB in<br />
1995)<br />
fruit<br />
resistant<br />
Source: Tabulated from Payot, 2005<br />
In 1984, the papaya ringspot virus (PRSV) outbreak created havoc in the flourishing<br />
papaya industry. PRSV reduces total production by 35%–41% and reduces yield by as much as<br />
90%–100%. Once an area has been infested, PRSV is there to stay: no eradication ef<strong>for</strong>t yet has<br />
been successful. All the Philippine cultivars/strains are susceptible to PRSV except <strong>for</strong> Sinta,<br />
which is moderately resistant. <strong>Biotechnology</strong>’s contribution is to produce PRSV-resistant papaya,<br />
developed locally, although the gene construct is imported, with PCARRD holding the license. It<br />
is currently undergoing contained field testing and is set to be commercialized by 2007. Public<br />
acceptance of this GMO, however, promises to be a tough challenge.<br />
Laude (2002) showed that cash costs comprise the bulk of production costs (75%);<br />
chemical inputs such as fertilizers and pesticides (36%) and hired labor (35%) contributed 71%.<br />
Varying price and cost-competitiveness of the GM papaya over the non-GM papaya were also<br />
reported. Using export parity prices, the analysis revealed greater-than-one price ratios <strong>for</strong> Solo<br />
GMO, non-GMO, and Sinta papaya, which implies that these fruits are price-competitive on the<br />
export market. Moreover, the non-GMO Solo papaya appears to be more price-competitive by<br />
15% over the GMO Solo and the non-GMO Sinta (Table 7). Laude observed that there was<br />
un<strong>for</strong>tunately bias in the world market against the GMO papaya. In fact, the price ascribed to the<br />
GMO papaya is almost half that of a non-GMO papaya’s border price. On the other hand, a nontransgenic<br />
Sinta papaya has about the same border price as that of a Solo GMO. Despite this, the<br />
Sinta papaya can still obtain a better price when exported than when sold locally, that is, if the<br />
export market reacts positively to Sinta.<br />
– 156 –